News: Sectors

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance Pro.CalendarSectors
08/13Marksans Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/13The European Innovation Council Awards the Acousort Project Acousome SEK 26 Million to Develop Technology for Exosome-Based Diagnostics
CI
08/13U.S. and Switzerland working on facilitating pharma trade - U.S. ambassador
RE
08/13Aoxin Q & M Dental Group Limited Reports Earnings Results for the Half Year Ended June 30, 2022
CI
08/13Nectar Lifesciences Limited Appoints Sanjit Singh Lamba as Additional Director
CI
08/13Luff Enterprises Ltd. completed the acquisition of National Green Biomed Ltd. (NG Biomed).
CI
08/1322,464 Ordinary Shares of Biome Australia Limited are subject to a Lock-Up Agreement Ending on 13-AUG-2022.
CI
08/12Resverlogix Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12ICoreConnect Inc. Reports Revenue Results for the Second Quarter Ended June 30, 2022
CI
08/12Akumin Inc. Announces Chief Financial Officer Transition
CI
08/12Evofem Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Appili Therapeutics Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/12Petros Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Eloxx Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Allarity Therapeutics, Inc. and R-Pharm U.S. Operating LLC Executes A Second Amendment to Certain Development, Option & License Agreement
CI
Discover
08/12SANUWAVE Health, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12AIkido Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Actinium Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12CNS Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Moleculin Biotech, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12SNDL Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Rubius Therapeutics, Inc. Announces Resignation of Natalie Holles as Member of the Board of Directors
CI
08/12ICoreConnect Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Correlate Infrastructure Partners Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12LogicMark, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Genprex, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Bright Minds Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
08/12Edesa Biotech, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
08/12Creative Medical Technology Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Know Labs, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
08/12Inhibikase Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12RenovoRx, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Praxis Precision Medicines, Inc. Announces Executive Changes
CI
08/12FSD Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12VYNE Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Unrivaled Brands, Inc. Appoints Mr. Sabas Carrillo as Interim Chief Executive Officer
CI
08/12Tenon Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Enveric Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12IN8bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Kiromic BioPharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Inhibitor Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Humanigen, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12NeuroBo Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Hoth Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12CEL-SCI Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
08/12Immix Biopharma, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12AgeX Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12RegeneRx Biopharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Nemaura Medical Inc. Reports Earnings Results for the First Quarter Ended June 30, 2022
CI
08/12Acurx Pharmaceuticals, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Soligenix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12MoonLake Immunotherapeutics Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Imago BioSciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Jasper Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12U.S. NeuroSurgical Holdings, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Bioteque Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12FDA Issues Warning Letter to Emergent Biosolutions After February Inspection
DJ
08/12AViTA Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Rapid Therapeutic Science Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12RenovaCare, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12SeqLL Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12International Stem Cell Corporation Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Regenicin, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended June 30, 2022
CI
08/12Fennec Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12Mydecine Innovations Group Inc. Announces Resignation of Directors
CI
Discover
08/12Seagen loses arbitration against Daiichi Sankyo over drug technology
RE
08/12Seagen loses arbitration ruling against Daiichi Sankyo
RE
08/12TRANSCRIPT : Sonida Senior Living, Inc., Q2 2022 Earnings Call, Aug 12, 2022
CI
08/12Eupraxia Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
CI
08/12TRANSCRIPT : Diagnósticos da América S.A., Q2 2022 Earnings Call, Aug 12, 2022
CI
Prev.2  3  4  5  6   7  8  9  10  11Next